Cary Street Partners Investment Advisory’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-754
Closed -$21.1K 798
2023
Q3
$21.1K Buy
754
+7
+0.9% +$240 ﹤0.01% 1099
2023
Q2
$27.6K Hold
747
﹤0.01% 973
2023
Q1
$22.4K Sell
747
-13
-2% -$428 ﹤0.01% 943
2022
Q4
$23.3K Buy
+760
New +$22.8K ﹤0.01% 936
2020
Q4
Sell
-392
Closed -$8K 432
2020
Q3
$8K Buy
+392
New +$7.56K ﹤0.01% 786

Other funds holding CC

Cary Street Partners Investment Advisory's CC Position: Q4 2023 in Review

Cary Street Partners Investment Advisory sold out of Chemours (CC) in Q4 2023, closing a stake of 754 shares — an estimated $21.1K sold.

Cary Street Partners Investment Advisory first reported a position in CC in Q3 2020 and held it in 5 quarters. The position peaked at $27.6K in Q2 2023. 469 funds tracked by Wall St. Rank hold CC as of Q4 2023.

  • Cary Street Partners Investment Advisory reported no remaining Chemours position as of Q4 2023 after selling out during the quarter.
  • Cary Street Partners Investment Advisory sold 754 Chemours shares in Q4 2023, an estimated $21.1K.
  • Cary Street Partners Investment Advisory first reported a position in Chemours in Q3 2020 and held it in 5 quarters.
  • Cary Street Partners Investment Advisory's Chemours position peaked at $27.6K in Q2 2023.
  • 469 funds tracked by Wall St. Rank held Chemours as of Q4 2023.

Based on Cary Street Partners Investment Advisory's 13F filing for Q4 2023, filed 5 Feb 2024.